Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers
Clinical trial NCT00503035 · COMPLETED
Trial details
- NCT number
- NCT00503035
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-20
- Primary completion
- 2021-04-02
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.